Repligen | RGEN - 贷款资金



金融业
股票价格
USD
资产
USD 2.95B
现金及等价物
USD 606.78M
销售成本
USD 94.09M
流动资产
USD 1.2B
流动负债
USD 132.66M
债务
USD 690.94M
EBIT
USD 21.13M
EBITDA
USD 43.77M
员工
1.78K
EPS每股收益
USD 0.54
股本和储备
USD 2.11B
销售毛利
USD 110.04M
债务利息支出
USD 5.66M
利息收入
USD 7.31M
贷款资金
USD 551.05M
市值
USD 9.28B
净收入
USD 5.01M
营业费用
USD 183M
营业利润
USD 21.13M
普通股股本
USD 56.43M
PE价格收益
105.09
税前利润
USD 14.15M
销售收入
USD 204M
销售和管理费用
USD 76.62M
股票
USD 186.6M
贸易债权人
USD 33.23M
应收帐款人
USD 157.71M


贷款资金 更改 日
Agilent USD 3.05B 1000K 2026-03
Align Technology USD 0 0 2024-12
Bio Techne USD 200M 60M 2026-03
BioMarin Pharmaceutical USD 3.53B 2.1B 2026-06
Bristol-Myers Squibb USD 42.09B 59M 2026-06
Bruker USD 1.81B 151.8M 2026-06
Charles River Laboratories USD 2.62B 43.15M 2026-06
Danaher USD 25.15B 7.59B 2026-06
Dentsply International USD 2B 10M 2026-06
General Electric Aerospace USD 17.16B 1.02B 2026-06
Henry Schein USD 2.3B 27M 2026-06
Illumina USD 1.49B 1000K 2026-06
IQVIA Holdings USD 13.7B 284M 2026-06
Mettler Toledo International USD 2.04B 116.92M 2026-06
Myriad Genetics USD 120.7M 400K 2026-06
OraSure Technologies USD 100K 17K 2025-12
Pacific Biosciences Of California USD 645.38M 223K 2025-12
Pfizer USD 60.5B 70M 2026-06
Repligen USD 551.05M 4.46M 2026-06
Revvity USD 2.63B 1.02M 2026-06
Standard Biotools USD 299K 0 2026-03
Thermo Fisher Scientific USD 39.18B 890M 2026-06
Waters USD 5.09B 129M 2026-06
West Pharmaceutical Services USD 202.9M 100K 2026-06